Skip to main content
SpringerLink
Log in

Role of neuropeptide Y in the regulation of kidney function

  • Chapter
NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics

Part of the book series: Experientia Supplementum ((EXS,volume 95))

Summary

The presence in the mammalian kidney of NPY and at least one of its receptor subtypes has been proven by several independent methodologies. Also, numerous studies using physiological and pharmacological approaches indicated that this peptide has the capacity to alter renal function. In particular, these studies suggest that NPY may exert renal vasoconstrictor and tubular actions that are species dependent, and may also influence renin secretion by the kidney. The question whether NPY plays an important role in the physiological regulation of renal hemodynamics and electrolyte excretion, remains largely unanswered at present. No major impairments in renal function have been reported in genetically models deficient in NPY or its Y1 receptor. Thus, additional studies are required to elucidate the role of NPY in the physiological and pathophysiological regulation of renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
eBook
USD 129.00
Price excludes VAT (USA)
Hardcover Book
USD 169.99
Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Hazelwood RL (1993) The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 202: 44–63

    CAS  PubMed  Google Scholar 

  2. Larhammar D (1996) Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 62: 1–11

    Article  CAS  PubMed  Google Scholar 

  3. Balasubramaniam A (2002) Clinical potentials of neuropeptide Y family of hormones. Am J Surg 183: 430–434

    Article  CAS  PubMed  Google Scholar 

  4. McDermott BJ, Millar BC, Piper HM (1993) Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res 27: 893–905

    CAS  PubMed  Google Scholar 

  5. Zukowska-Grocec Z, Wahlestedt C (1993) Origin and actions of neuropeptide Y in the cardiovascular system. In: The Biology of Neuropeptide Y and Related Peptides. Colmers WF, Wahlestedt C (Eds) Humana Press, Totowa, 315–388

    Google Scholar 

  6. Cox HM (1998) Peptidergic regulation of intestinal ion transport. A major role for neuropeptide Y and the pancreatic polypeptides. Digestion 59: 395–399

    Article  CAS  PubMed  Google Scholar 

  7. Playford RJ, Cox HM (1996) Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci 17: 436–438

    Article  CAS  PubMed  Google Scholar 

  8. Persson PB, Gimpl G, Lang RE (1990) Importance of neuropeptide Y in the regulation of kidney function. Ann NY Acad Sci 611: 156–165

    CAS  PubMed  Google Scholar 

  9. Bischoff A, Michel MC (1998) Renal effects of neuropeptide Y. Pflugers Arch 435: 443–453

    Article  CAS  PubMed  Google Scholar 

  10. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659–660

    Article  CAS  PubMed  Google Scholar 

  11. Ballesta J, Polak JM, Allen JM, Bloom SR (1984) The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY. Histochemistry 80: 483–485

    Article  CAS  PubMed  Google Scholar 

  12. Chevendra V, Weaver LC (1992) Distributions of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine. Neuroscience 50: 727–743

    Article  CAS  PubMed  Google Scholar 

  13. Knight DS, Fabre RD, Beal JA (1989) Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in the rat kidney. Am J Anat 184: 190–204

    Article  CAS  PubMed  Google Scholar 

  14. Norvell JE, MacBride RG (1989) Neuropeptide Y (NPY)-like immunoreactive nerve fibers in the human and monkey (Macaca fascicularis) kidney. Neurosci Lett 105: 63–67

    Article  CAS  PubMed  Google Scholar 

  15. Reinecke M, Forssmann WG (1988) Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry 89: 1–9

    Article  CAS  PubMed  Google Scholar 

  16. Allen JM, Polak JM, Rodrigo J, Darcy K, Bloom SR (1985) Localisation of neuropeptide Y in nerves of the rat cardiovascular system and the effect of 6-hydroxydopamine. Cardiovasc Res 19: 570–577

    CAS  PubMed  Google Scholar 

  17. Grouzmann E, Alvarez-Bolado G, Meyer C, Osterheld MC, Burnier M, Brunner HR, Waeber B (1994) Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue. Peptides 15: 1377–1382

    Article  CAS  PubMed  Google Scholar 

  18. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143–150

    CAS  PubMed  Google Scholar 

  19. Malmstrom RE (2002) Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions. Eur J Pharmacol 447: 11–30

    CAS  PubMed  Google Scholar 

  20. Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumoto T, Shimizu T, Noma M (1995) Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J Biol Chem 270: 30102–30110

    Article  CAS  PubMed  Google Scholar 

  21. Wharton J, Gordon L, Byrne J, Herzog H, Selbie LA, Moore K, Sullivan MH, Elder MG, Moscoso G, Taylor KM et al. (1993) Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 90: 687–691

    CAS  PubMed  Google Scholar 

  22. Blaze CA, Mannon PJ, Vigna SR, Kherani AR, Benjamin BA (1997) Peptide YY receptor distribution and subtype in the kidney: effect on renal hemodynamics and function in rats. Am J Physiol 273: F545–F553

    CAS  PubMed  Google Scholar 

  23. Bischoff A, Avramidis P, Erdbrugger W, Munter K, Michel MC (1997) Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol 120: 1335–1343

    CAS  PubMed  Google Scholar 

  24. Bischoff A, Michel MC (1999) Emerging functions for neuropeptide Y5 receptors. Trends Pharmacol Sci 20: 104–106

    Article  CAS  PubMed  Google Scholar 

  25. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382: 168–171

    Article  CAS  PubMed  Google Scholar 

  26. el Din MM, Malik KU (1988) Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin. J Pharmacol Exp Ther 246: 479–484

    PubMed  Google Scholar 

  27. Chen H, Bischoff A, Schafers RF, Wambach G, Philipp T, Michel MC (1997) Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y. J Auton Pharmacol 17: 137–146

    Article  CAS  PubMed  Google Scholar 

  28. Allen JM, Raine AE, Ledingham JG, Bloom SR (1985) Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci (Lond) 68: 373–377

    CAS  Google Scholar 

  29. Bischoff A, Erdbrugger W, Smits J, Michel MC (1996) Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction. J Physiol 495(Pt 2): 525–534

    CAS  PubMed  Google Scholar 

  30. Bischoff A, Stickan-Verfurth M, Michel MC (1997) Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats. Pflugers Arch 434: 57–62

    Article  CAS  PubMed  Google Scholar 

  31. Minson R, McRitchie R, Chalmers J (1989) Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J Auton Nerv Syst 27: 139–146

    Article  CAS  PubMed  Google Scholar 

  32. Minson RB, McRitchie RJ, Morris MJ, Chalmers JP (1990) Effects of neuropeptide Y on cardiac performance and renal blood flow in conscious normotensive and renal hypertensive rabbits. Clin Exp Hypertens A 12: 267–284

    CAS  PubMed  Google Scholar 

  33. Pernow J, Lundberg JM (1989) Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig. Acta Physiol Scand 136: 507–517

    CAS  PubMed  Google Scholar 

  34. Playford RJ, Mehta S, Upton P, Rentch R, Moss S, Calam J, Bloom S, Payne N, Ghatei M, Edwards R et al. (1995) Effect of peptide YY on human renal function. Am J Physiol 268: F754–F759

    CAS  PubMed  Google Scholar 

  35. Dietrich MS, Fretschner M, Nobiling R, Persson PB, Steinhausen M (1991) Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity. J Physiol 444: 303–315

    CAS  PubMed  Google Scholar 

  36. Modin A, Malmstrom RE, Meister B (1999) Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA. Neuropeptides 33: 253–259

    Article  CAS  PubMed  Google Scholar 

  37. Lundberg JM, Modin A (1995) Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Br J Pharmacol 116: 2971–2982

    CAS  PubMed  Google Scholar 

  38. Hackenthal E, Aktories K, Jakobs KH, Lang RE (1987) Neuropeptide Y inhibits renin release by a pertussis toxin-sensitie mechanism. Am J Physiol 252: F543–F550

    CAS  PubMed  Google Scholar 

  39. Bischoff A, Freund A, Michel MC (1997) The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y. Naunyn Schmiedebergs Arch Pharmacol 356: 635–640

    Article  CAS  PubMed  Google Scholar 

  40. Persson PB, Ehmke H, Nafz B, Lang R, Hackenthal E, Nobiling R, Dietrich MS, Kirchheim HR (1991) Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs. J Physiol 444: 289–302

    CAS  PubMed  Google Scholar 

  41. Evequoz D, Aubert JF, Nussberger J, Biollaz J, Diezi J, Brunner HR, Waeber B (1996) Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats. Nephron 73: 467–472

    CAS  PubMed  Google Scholar 

  42. Denton KM, Luff SE, Shweta A, Anderson WP (2004) Differential neural control of glomerular ultrafiltration. Clin Exp Pharmacol Physiol 31: 380–386

    CAS  PubMed  Google Scholar 

  43. Smyth DD, Blandford DE, Thom SL (1988) Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat. Eur J Pharmacol 152: 157–162

    Article  CAS  PubMed  Google Scholar 

  44. Echtenkamp SF, Dandridge PF (1989) Renal actions of neuropeptide Y in the primate. Am J Physiol 256: F524–F531

    CAS  PubMed  Google Scholar 

  45. Bischoff A, Michel MC (2000) Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion. Can J Physiol Pharmacol 78: 93–99

    Article  CAS  PubMed  Google Scholar 

  46. Smyth DD, Wilson JR, Seidlitz E, Thom SL (1989) Effects of central and peripheral neuropeptide Y on sodium and water excretion in the rat. Physiol Behav 46: 9–11

    Article  CAS  PubMed  Google Scholar 

  47. Granger JP, Alexander BT, Llinas M (2002) Mechanisms of pressure natriuresis. Curr Hypertens Rep 4: 152–159

    PubMed  Google Scholar 

  48. Bischoff A, Rascher W, Michel MC (1998) Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis. Am J Physiol 275: F502–F509

    CAS  PubMed  Google Scholar 

  49. Bischoff A, Neumann A, Dendorfer A, Michel MC (1999) Is bradykinin a mediator of renal neuropeptide Y effects? Pflugers Arch 438: 797–803

    CAS  PubMed  Google Scholar 

  50. Bischoff A, Limmroth V, Michel MC (1998) Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats. J Pharmacol Exp Ther 286: 704–708

    CAS  PubMed  Google Scholar 

  51. Matsuda H, Brumovsky PR, Kopp J, Pedrazzini T, Hokfelt T (2002) Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues. J Comp Neurol 449: 390–404

    Article  CAS  PubMed  Google Scholar 

  52. Aubert JF, Walker P, Grouzmann E, Nussberger J, Brunner HR, Waeber B (1992) Inhibitory effect of neuropeptide Y on stimulated renin secretion of awake rats. Clin Exp Pharmacol Physiol 19: 223–228

    CAS  PubMed  Google Scholar 

  53. Corder R, Vallotton MB, Lowry PJ, Ramage AG (1989) Neuropeptide Y lowers plasma rennin activity in the anaesthetised cat. Neuropeptides 14: 111–114

    Article  CAS  PubMed  Google Scholar 

  54. Zelis R, Nussberger J, Clemson B, Waeber B, Grouzmann E, Brunner HR (1994) Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats. J Cardiovasc Pharmacol 24: 896–899

    CAS  PubMed  Google Scholar 

  55. Waeber B, Evequoz D, Aubert JF, Fluckiger JP, Juillerat L, Nussberger J, Brunner HR (1990) Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertens 8: 21–25

    CAS  PubMed  Google Scholar 

  56. Pedrazzini T (2004) Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts. Neuropeptides 38: 267–275

    Article  CAS  PubMed  Google Scholar 

  57. Dillingham MA, Anderson RJ (1989) Mechanism of neuropeptide Y inhibition of vasopressin action in rat cortical collecting tubule. Am J Physiol 256: F408–F413

    CAS  PubMed  Google Scholar 

  58. Ohtomo Y, Meister B, Hokfelt T, Aperia A (1994) Coexisting NPY and NE synergistically regulate renal tubular Na+, K+-ATPase activity. Kidney Int 45: 1606–1613

    CAS  PubMed  Google Scholar 

  59. Ohtomo Y, Ono S, Zettergren E, Sahlgren B (1996) Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways. Acta Physiol Scand 158: 97–105

    Article  CAS  PubMed  Google Scholar 

  60. Holtback U, Ohtomo Y, Forberg P, Sahlgren B, Aperia A (1998) Neuropeptide Y shifts equilibrium between alpha-and beta-adrenergic tonus in proximal tubule cells. Am J Physiol 275: F1–F7

    CAS  PubMed  Google Scholar 

  61. Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189–200

    Article  CAS  PubMed  Google Scholar 

  62. Costoli T, Sgoifo A, Stilli D, Flugge G, Adriani W, Laviola G, Fuchs E, Pedrazzini T, Musso E (2005) Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor. Neurosci Biobehav Rev 29: 113–123

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology & Biophysics, The B. Rappaport Faculty of Medicine, Technion, IIT, P.O. Box 9649, Haifa, 31096, Israel

    Joseph Winaver & Zaid Abassi

Authors
  1. Joseph Winaver
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zaid Abassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology and Biophysics, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC, 20057, USA

    Zofia Zukowska

  2. Wyeth Research, Building A3153, 500 Arcola Rd, Collegeville, PA, 19426, USA

    Giora Z. Feuerstein

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Winaver, J., Abassi, Z. (2006). Role of neuropeptide Y in the regulation of kidney function. In: Zukowska, Z., Feuerstein, G.Z. (eds) NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Experientia Supplementum, vol 95. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7417-9_9

Download citation

Publish with us

Policies and ethics

Search

Navigation